相关实验视频
Updated: Jun 19, 2025

08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.0K
一个双特异的纳米系统激活了骨髓中的内源性自然杀手细胞,用于血液恶性瘤治疗
Yanqin Zhang1, Yanfang Deng1, Yuewen Zhai1
1State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China.
Nature nanotechnology
|July 23, 2024
概括
一个新的骨髓向纳米系统,CSF@E-Hn,有效地消除了血液性恶性瘤细胞. 这种创新疗法还促进干细胞分化和免疫记忆,防止长期复发.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 血液性恶性瘤起源于骨髓,缺乏有效的向疗法.
- 目前的治疗方法在准骨髓微环境中的瘤细胞方面面临挑战.
研究的目的:
- 开发和评估一种新的骨髓向纳米系统 (CSF@E-Hn) 用于治疗血液恶性瘤.
- 为了研究纳米系统的治疗疗效和骨髓微环境调制.
主要方法:
- 构建CSF@E-Hn:以骨髓为目标的纳米纤维,装饰着aPD-L1/aNKG2D连接体,并装载着殖民地刺激因子 (CSF).
- 在急性髓性白血病和多发性髓瘤的小鼠模型中的体内验证.
- 骨髓处理后微环境的全面分析.
主要成果:
- CSF@E-Hn成功准了骨髓,并促进了自然杀手 (NK) 细胞介导的瘤细胞消除.
- 在急性髓性白血病和多发性髓瘤小鼠模型中证明了治疗效果.
- 纳米系统促进了造血干细胞的分化,增强了记忆T细胞的产生,并保持了骨平衡,防止复发.
结论:
- 通过向骨髓和调节免疫微环境,CSF@E-Hn是治疗血液性恶性瘤的有希望的策略.
- 该纳米系统支持长期缓解和骨健康,解决癌症治疗中的关键未满足需求.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
883
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
883
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

